MPEG LA builds new biotech licensing programmes and remains hopeful on CRISPR pool
Trend suggests a growing similarity between patent monetisation models in the life sciences and high-tech sectors
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Register now
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.
Subscribe now